Previous 10 |
home / stock / zldaf / zldaf news
PERTH, Australia , Jan. 28, 2020 /PRNewswire/ -- Zelira Therapeutics Limited (ASX: ZLD, OTCQB: ZLDAF) is pleased to announce a collaboration with the Parkinson's Foundation, one of the United States of America's leading communities for people living with Parkinson's diseas...
PERTH, Australia , Dec. 3, 2019 /PRNewswire/ -- Zelira Therapeutics Ltd (ASX: ZLD, OTCQB: ZLDAF, Zelira), formerly Zelda Therapeutics Ltd, announced today it will bring its HOPE® Franchise to the state of Louisiana with a licensing agreement that will generate immediate ...
An Australian medical cannabis company will see its products distributed in the United Kingdom thanks to its partner. On Thursday (November 21), Zelda Therapeutics (ASX: ZLD ,OTCQB:ZLDAF) confirmed a new non-exclusive agreement with Health House Holdings to start the distribution for ...
NEW YORK , Oct. 14, 2019 /PRNewswire/ -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the October 10 th conference are now available for on-demand viewing at VirtualInvestorConferences.com. RE...
The following slide deck was published by Zelda Therapeutics Limited in conjunction with this Read more ...
NEWTOWN SQUARE, Pa. , Oct. 9, 2019 /PRNewswire/ -- Zelda Therapeutics Limited (ASX: ZLD, OTCQB: ZLDAF) ("Zelda") is pleased to announce a proposed merger of equals with Ilera Therapeutics LLC (Ilera Therapeutics), a privately held medicinal cannabis and cannabinoid science company based...
Live Investor Conference & Webinar: Executives from Small and MicroCap companies present October 10th Live Investor Conference & Webinar: Executives from Small and MicroCap companies present October 10th Canada NewsWire NEW YORK, Oct. 4, 2019 Company executives wi...
News, Short Squeeze, Breakout and More Instantly...
Zelda Therapeutics Ltd Company Name:
ZLDAF Stock Symbol:
OTCMKTS Market:
Zelda Therapeutics Ltd Website:
Zelira Therapeutics Ltd (ASX: ZLD) (OTCQB: ZLDAF) said that it has funding to conduct mid-to-late-stage FDA trials for its cannabinoid-based drug to treat autism spectrum disorder (ASD). The company received $8.6 million in funding from U.S.-based investment firm Cantheon Capital LLC to con...
Zelira Therapeutics Launches ZYRAYDI™ B2B Technology to Create Pharma-grade Cannabis Capsules & Tablets for Global Markets Zelira Therapeutics Launches ZYRAYDI™ B2B Technology to Create Pharma-grade Cannabis Capsules & Tablets for Global Markets PR News...
Zelira Therapeutics Ltd (ASX: ZLD,OTC-QB: ZLDAF ), recieved formal approval from German regulatory authority BfArM to launch in the German medical cannabis market for its new insomnia medication Zenivol. Zenivol is the first clinically validated , pharmaceutic...